- Home
- KOD vs SRV Comparison
KOD vs SRV Comparison
Compare KOD & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- SRV
- Stock Information
- Founded
- KOD 2009
- SRV 2007
- Country
- KOD United States
- SRV United States
- Employees
- KOD N/A
- SRV N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- SRV Finance Companies
- Sector
- KOD Health Care
- SRV Finance
- Exchange
- KOD Nasdaq
- SRV Nasdaq
- Market Cap
- KOD 186.3M
- SRV 123.3M
- IPO Year
- KOD 2018
- SRV N/A
- Fundamental
- Price
- KOD $8.72
- SRV $42.29
- Analyst Decision
- KOD Hold
- SRV
- Analyst Count
- KOD 5
- SRV 0
- Target Price
- KOD $6.80
- SRV N/A
- AVG Volume (30 Days)
- KOD 473.7K
- SRV 33.9K
- Earning Date
- KOD 11-14-2024
- SRV 01-01-0001
- Dividend Yield
- KOD N/A
- SRV 13.38%
- EPS Growth
- KOD N/A
- SRV N/A
- EPS
- KOD N/A
- SRV N/A
- Revenue
- KOD N/A
- SRV N/A
- Revenue This Year
- KOD N/A
- SRV N/A
- Revenue Next Year
- KOD N/A
- SRV N/A
- P/E Ratio
- KOD N/A
- SRV N/A
- Revenue Growth
- KOD N/A
- SRV N/A
- 52 Week Low
- KOD $2.19
- SRV $30.73
- 52 Week High
- KOD $11.60
- SRV $44.30
- Technical
- Relative Strength Index (RSI)
- KOD 64.72
- SRV 40.18
- Support Level
- KOD $8.03
- SRV $44.46
- Resistance Level
- KOD $9.55
- SRV $45.14
- Average True Range (ATR)
- KOD 0.89
- SRV 1.10
- MACD
- KOD -0.08
- SRV -0.45
- Stochastic Oscillator
- KOD 36.51
- SRV 31.62
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.